TI
ASND icon

Trexquant Investment’s Ascendis Pharma A/S ASND Stock Holding History

Trexquant Investment’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.6M Sell
47,269
-18,248
-28% -$4.26M 0.07% 342
2026
Q1 		$15M Buy
65,517
+6,492
+11% +$1.46M 0.11% 241
2025
Q4 		$12.6M Buy
59,025
+31,440
+114% +$6.49M 0.11% 244
2025
Q3 		$5.48M Sell
27,585
-36,550
-57% -$6.82M 0.06% 518
2025
Q2 		$11.1M Buy
64,135
+20,375
+47% +$3.32M 0.12% 213
2025
Q1 		$6.82M Buy
43,760
+16,693
+62% +$2.38M 0.08% 379
2024
Q4 		$3.73M Buy
27,067
+19,010
+236% +$2.5M 0.04% 630
2024
Q3 		$1.2M Sell
8,057
-15,640
-66% -$2.11M 0.02% 987
2024
Q2 		$3.23M Buy
23,697
+3,408
+17% +$464K 0.05% 553
2024
Q1 		$3.07M Buy
20,289
+10,421
+106% +$1.49M 0.06% 486
2023
Q4 		$1.24M Buy
+9,868
New +$984K 0.03% 746
2023
Q1 		– Sell
-2,050
Closed -$250K – 1427
2022
Q4 		$250K Buy
+2,050
New +$238K 0.01% 1164
2021
Q3 		– Sell
-2,042
Closed -$269K – 1118
2021
Q2 		$269K Buy
+2,042
New +$272K 0.02% 766
2021
Q1 		– Sell
-3,753
Closed -$626K – 1109
2020
Q4 		$626K Buy
+3,753
New +$621K 0.07% 377
2018
Q1 		– Sell
-6,999
Closed -$280K – 1055
2017
Q4 		$280K Sell
6,999
-1,833
-21% -$66.6K 0.03% 780
2017
Q3 		$320K Buy
8,832
+32
+0.4% +$918 0.08% 439
2017
Q2 		$244K Buy
+8,800
New +$233K 0.07% 570

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Trexquant Investment's ASND Position: Q2 2026 in Review

Trexquant Investment reduced its Ascendis Pharma A/S (ASND) stake by 28% in Q2 2026, selling an estimated $4.26M and leaving 47,269 shares worth $12.6M. The position accounts for 0.07% of the portfolio, ranked #342.

Trexquant Investment first reported a position in ASND in Q2 2017 and has held it in 17 quarters since. The position peaked at $15M in Q1 2026. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Trexquant Investment held 47,269 shares of Ascendis Pharma A/S worth $12.6M as of Q2 2026.
  • Trexquant Investment sold 18,248 Ascendis Pharma A/S shares in Q2 2026, an estimated $4.26M.
  • Ascendis Pharma A/S made up 0.07% of Trexquant Investment's portfolio in Q2 2026, its #342 holding.
  • Trexquant Investment first reported a position in Ascendis Pharma A/S in Q2 2017 and has held it in 17 quarters since.
  • Trexquant Investment's Ascendis Pharma A/S position peaked at $15M in Q1 2026.
  • 312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.